Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials

@article{Hodson2005AntiviralMT,
  title={Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials},
  author={Elisabeth M. Hodson and Cheryl Jones and Angela C Webster and Giovanni F M Strippoli and Jonathan C Craig},
  journal={The Lancet},
  year={2005},
  volume={365},
  pages={2105-2115}
}
BACKGROUND Antiviral prophylaxis is commonly used in recipients of solid-organ transplants with the aim of preventing the clinical syndrome associated with cytomegalovirus infection. We undertook a systematic review to investigate whether this approach affects risks of cytomegalovirus disease and death. METHODS Randomised controlled trials of prophylaxis with antiviral medications for cytomegalovirus disease in solid-organ-transplant recipients were identified. Data were combined in meta… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 125 extracted citations

Cytomegalovirus infection after kidney transplantation and long-term graft loss.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia • 2017
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…